Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study

References

• Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety. 2010;27:351–364. doi:10.1002/da.2063420037917
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105. doi:10.1001/jama.289.23.309512813115
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Hong JP, Tian-Mei S, et al. Clinical features of depression in Asia: results of a large prospective, cross-sectional study. Asia Pac Psychiatry. 2013;5:259–267. doi:10.1111/j.1758-5872.2012.00209.x24038919
   PubMed Web of Science ®Google Scholar
• Lin CH, Yen YC, Chen MC, Chen CC. Depression and pain impair daily functioning and quality of life in patients with major depressive disorder. J Affect Disord. 2014;166:173–178. doi:10.1016/j.jad.2014.03.03925012428
   PubMed Web of Science ®Google Scholar
• IsHak WW, James DM, Mirocha J, et al. Patient-reported functioning in major depressive disorder. Ther Adv Chronic Dis. 2016;7:160–169. doi:10.1177/204062231663976927347363
   PubMed Web of Science ®Google Scholar
• Kim JM, Chalem Y, di Nicola S, et al. A cross-sectional study of functional disabilities and perceived cognitive dysfunction in patients with major depressive disorder in South Korea: the PERFORM-K study. Psychiatry Res. 2016;239:353–361. doi:10.1016/j.psychres.2016.01.02226908289
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Nakagome K, Asami Y, Pappadopulos EA, Boucher M. Restoring function in major depressive disorder: a systematic review. J Affect Disord. 2017;215:299–313. doi:10.1016/j.jad.2017.02.02928364701
   PubMed Web of Science ®Google Scholar
• Katon W. The impact of depression on workplace functioning and disability costs. Am J Manag Care. 2009;15(11 Suppl):S322–S327.20088628
   PubMedGoogle Scholar
• Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27:78–89. doi:10.1002/da.v27:119569060
   PubMed Web of Science ®Google Scholar
• Gelenberg AJ. The prevalence and impact of depression. J Clin Psychiatry. 2010;71:e06. doi:10.4088/JCP.8001tx17c
   PubMed Web of Science ®Google Scholar
• Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35:1–14. doi:10.1016/j.psc.2011.11.00522370487
   PubMed Web of Science ®Google Scholar
• Zimmerman M, McGlinchey JB, Posternak MA, et al. How should remission from depression be defined? The depressed patient’s perspective. Am J Psychiatry. 2006;163:148–150. doi:10.1176/appi.ajp.163.12.218916390903
   PubMed Web of Science ®Google Scholar
• Lam RW, McIntosh D, Wang J, et al; CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry. 2016;61:510–523. doi:10.1177/070674371665941627486151
   PubMed Web of Science ®Google Scholar
• Israel JA. Remission in depression: definition and initial treatment approaches. J Psychopharmacol. 2006;20(3 Suppl):5–10. doi:10.1177/1359786806064306
   Web of Science ®Google Scholar
• Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord. 2007;9:25–37. doi:10.1111/bdi.2007.9.issue-1-217391347
   PubMed Web of Science ®Google Scholar
• McKnight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29:243–259. doi:10.1016/j.cpr.2009.01.00519269076
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Morris DW, Wisniewski SR, et al. Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry. 2013;170:633–641. doi:10.1176/appi.ajp.2012.1202025023558394
   PubMed Web of Science ®Google Scholar
• IsHak WW, Greenberg JM, Cohen RM. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D). J Affect Disord. 2013;151:59–65. doi:10.1016/j.jad.2013.08.00223790554
   PubMed Web of Science ®Google Scholar
• Naismith SL, Longley WA, Scott EM, Hickie IB. Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry. 2007;7:32. doi:10.1186/1471-244X-7-3217634111
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Mclntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59:649–654. doi:10.1177/07067437140590120625702365
   PubMed Web of Science ®Google Scholar
• Gonda X, Pompili M, Serafini G, Carvalho AF, Rihmer Z, Dome P. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry. 2015;14:27. doi:10.1186/s12991-015-0068-926396586
   PubMed Web of Science ®Google Scholar
• Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41:1165–1174. doi:10.1017/S003329171000191120932356
   PubMed Web of Science ®Google Scholar
• Evans VC, Iverson GL, Yatham LN, Lam RW. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75:1359–1370. doi:10.4088/JCP.13r0893925551235
   PubMed Web of Science ®Google Scholar
• Hammer-Helmich L, Haro JM, Jönsson B, et al. Functional impairment in patients with major depressive disorder: the 2-year PERFORM study. Neuropsychiatr Dis Treat. 2018;14:239–249. doi:10.2147/NDT.S14609829386897
   PubMed Web of Science ®Google Scholar
• Bollen KA. Structural Equations with Latent Variables. Hoboken, NJ: John Wiley & Sons, Inc; 1989.
   Google Scholar
• Haro JM, Lamy F-X, Jönsson B, et al. Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study. BMC Psychiatry. 2018;18:80. doi:10.1186/s12888-018-1657-329587672
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi:10.1046/j.1525-1497.2001.016009606.x11556941
   PubMed Web of Science ®Google Scholar
• Sullivan MJ, Edgley K, Dehoux E. A survey of multiple sclerosis. Part 1. Perceived cognitive problems and compensatory strategy use. Can J Rehabil. 1990;4:99–105.
   Google Scholar
• National Multiple Sclerosis Society. Multiple Sclerosis Quality of Life Inventory: A User’s Manual. New York, NY: The Consortium of Multiple Sclerosis Centers Health Services Research Subcommittee, The National Multiple Sclerosis Society; 1997.
   Google Scholar
• Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95. doi:10.1097/00004850-199606003-00015
   PubMed Web of Science ®Google Scholar
• Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol. 2008;23:70–83. doi:10.1097/YIC.0b013e3282f2b4d618301121
   PubMed Web of Science ®Google Scholar
• Rosseel Y. lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1–36. doi:10.18637/jss.v048.i02
   Web of Science ®Google Scholar
• Robins JM. A new approach to causal inference in mortality studies with sustained exposure periods – application to control of the healthy worker survivor effect. Mathematical Modelling. 1986;7:1393–1512. doi:10.1016/0270-0255(86)90088-6
   Web of Science ®Google Scholar
• Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:669–688. doi:10.1093/biomet/82.4.669
   Web of Science ®Google Scholar
• Snowden JM, Rose S, Mortimer KM. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am J Epidemiol. 2011;173:731–738. doi:10.1093/aje/kwq47221415029
   PubMed Web of Science ®Google Scholar
• Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145:39–48. doi:10.1016/j.psychres.2005.11.01117045658
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30:515–527. doi:10.1002/da.2206323468126
   PubMed Web of Science ®Google Scholar
• Bortolato B, Carvalho AF, McIntyre RS. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 2014;13:1804–1818. doi:10.2174/187152731366614113020382325470396
   PubMed Web of Science ®Google Scholar
• Woo YS, Rosenblat JD, Kakar R, Bahk W-M, McIntyre RS. Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin Psychopharmacol Neurosci. 2016;14:1–16. doi:10.9758/cpn.2016.14.1.126792035
   PubMed Web of Science ®Google Scholar
• Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018;14:1339–1350. doi:10.2147/NDT29872301
   PubMed Web of Science ®Google Scholar
• Adler DA, McLaughlin TJ, Rogers WH, et al. Job performance deficits due to depression. Am J Psychiatry. 2006;163:1569–1576. doi:10.1176/appi.ajp.163.12.218916946182
   PubMed Web of Science ®Google Scholar
• Rytsälä HJ, Melartin TK, Leskelä US, et al. Determinants of functional disability and social adjustment in major depressive disorder: a prospective study. J Nerv Ment Dis. 2006;194:570–576. doi:10.1097/01.nmd.0000230394.21345.c416909064
   PubMed Web of Science ®Google Scholar
• Iosifescu DV. The relation between mood, cognition and psychosocial functioning in psychiatric disorders. Eur Neuropsychopharmacol. 2012;22(Suppl 3):S499–S504. doi:10.1016/j.euroneuro.2012.08.00222959115
   PubMed Web of Science ®Google Scholar
• Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011;134:20–31. doi:10.1016/j.jad.2010.11.01121163534
   PubMed Web of Science ®Google Scholar
• Ladegaard N, Videbech P, Lysaker PH, Larsen ER. The course of social cognitive and metacognitive ability in depression: deficits are only partially normalized after full remission of first episode major depression. Br J Clin Psychol. 2016;55:269–286. doi:10.1111/bjc.2016.55.issue-326566732
   PubMed Web of Science ®Google Scholar
• Saragoussi D, Touya M, Haro JM, et al. Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Neuropsychiatr Dis Treat. 2017;13:2151–2165. doi:10.2147/NDT.S13634328860772
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK. The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol. 2016;10:pyw055. doi:10.1093/ijnp/pyw055
   Web of Science ®Google Scholar
• Baune BT, Brignone M, Larsen KG. A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2018;21:97–107. doi:10.1093/ijnp/pyx07029053849
   PubMed Web of Science ®Google Scholar
• Chokka P, Bougie J, Rampakakis E, Proulx J. Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD). CNS Spectr. 2019;24:338–347. doi:10.1017/S109285291800091329792585
   PubMed Web of Science ®Google Scholar
• Chokka P, Bougie J, Proulx J, Holmegaard Tvistholm A, Ettrup A. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study. CNS Spectr. 2019;1–12. [Epub ahead of print]. doi:10.1017/S1092852919000786
   Web of Science ®Google Scholar
• Andresen R, Caputi P, Oades LG. Do clinical outcome measures assess consumer-defined recovery? Psychiatry Res. 2010;177:309–317. doi:10.1016/j.psychres.2010.02.01320227768
   PubMed Web of Science ®Google Scholar
• IsHak WW, Mirocha J, Pi S, et al. Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues Clin Neurosci. 2014;16:171–183.25152656
   PubMed Web of Science ®Google Scholar
• Slade M, Longden E. Empirical evidence about recovery and mental health. BMC Psychiatry. 2015;15:285. doi:10.1186/s12888-015-0678-426573691
   PubMed Web of Science ®Google Scholar
• Oliveira-Maia AJ, Mendonça C, Pessoa MJ, Camacho M, Gago J. The mental health recovery measure can be used to assess aspects of both customer-based and service-based recovery in the context of severe mental illness. Front Psychol. 2016;7:1679. doi:10.3389/fpsyg.2016.0167927857698
   PubMed Web of Science ®Google Scholar
• Fava M, Mahableshwarkar AR, Jacobson W, et al. What is the overlap between subjective and objective cognitive impairments in MDD? Ann Clin Psychiatry. 2018;30:176–184.30028891
   PubMed Web of Science ®Google Scholar
• Lovera J, Bagert B, Smoot KH, et al. Correlations of perceived deficits questionnaire of multiple sclerosis quality of life inventory with Beck depression inventory and neuropsychological tests. J Rehabil Res Dev. 2006;43:73–82. doi:10.1682/JRRD.2004.09.011816847773
   PubMed Web of Science ®Google Scholar
• Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015;40:2025–2037. doi:10.1038/npp.2015.5225687662
   PubMed Web of Science ®Google Scholar
• Lam RW, Lamy FX, Danchenko N, et al. Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:2861–2877. doi:10.2147/NDT.S17518830464471
   PubMed Web of Science ®Google Scholar